SEARCH

SEARCH BY CITATION

References

  • Ait-Mohand H, Bonmarchand M, Guiguet M et al. (2008) Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study. HIV Medicine 9, 738746.
  • Boyer S, Marcellin F, Ongolo-Zogo P et al. (2009) Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bulletin of the World Health Organization 87, 279287.
  • Braitstein P, Brinkhof MW, Dabis F et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367, 817824.
  • Brinkhof MW, Dabis F, Myer L et al. (2008) Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bulletin of the World Health Organization 86, 559567.
  • Brinkhof MWG, Pujades-Rodriguez M & Egger M (2009) Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 6, e5790.
  • Cornell M, Myer L, Kaplan R, Bekker LG & Wood R (2009) The impact of gender and income on survival and retention in a South African antiretroviral therapy programme. Tropical Medicine and International Health 14, 722731.
  • DART Trial Team (2010) Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non inferiority trial. Lancet 375, 123131.
  • Forster M, Bailey C, Brinkhof MW et al. (2008) Electronic medical record systems, data quality and lost to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bulletin of the World Health Organization 86, 939947.
  • Harries AD, Schouten EJ, Makombe SD et al. (2007) Ensuring uninterrupted supplies of antiretroviral drugs in resource-poor settings: an example from Malawi. Bulletin of the World Health Organization 85, 152155.
  • Harries AD, Zachariah R, Jahn A, Schouten EJ & Kamoto K (2009) Scaling up antiretroviral therapy in Malawi – implications for managing other chronic diseases in resource-limited countries. Journal of Acquired Immune Deficiency Syndromes 52, S14S16.
  • Jaffar S, Amuron B, Foster S et al. (2009) Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 374, 20802089.
  • Janssens B, Van Damme W, Raleigh B et al. (2007) Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bulletin of the World Health Organization 85, 880885.
  • Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R & Harrison TS (2009) Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clinical Infectious Disease 48, 856862.
  • Kaplan R, Orrell C, Zwane E, Bekker LG & Wood R (2008) Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS 22, 16791681.
  • Lawn SD, Myer L, Harling G, Orrell C, Bekker LG & Wood R (2006) Determinants of mortality and non death losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Disease 43, 770776.
  • Lawn SD, Kaplan R, Wood R & Bekker L (2007) Promoting retention in care: an effective model in an antiretroviral treatment service in South Africa. Clinical Infectious Disease 45, 803.
  • Lawn SD, Harries AD, Anglaret X, Myer L & Wood R (2008) Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22, 18971908.
  • Lawn SD, Little F, Bekker LG et al. (2009) Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 23, 335342.
  • Lawn SD, Harries AD & Wood R (2010) Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Current Opinion in HIV and AIDS 5, 1826.
  • Lester R, Gelmon L & Plummer FA (2006) Cell phones: tightening the communication gap in resource-limited antiretroviral programmes? AIDS 20, 22422244.
  • Libamba E, Makombe S, Mhango E et al. (2006) Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bulletin of the World Health Organization 84, 320326.
  • Lowrance D, Makombe S, Harries A et al. (2007) Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi. Journal of Acquired Immune Deficiency Syndromes 46, 5661.
  • Makombe SD, Lowrance DW, Kamoto K et al. (2007) Providing insecticide treated bed nets in antiretroviral treatment clinics in Malawi: a pilot study. Malawi Medical Journal 19, 111115.
  • Massaquoi M, Zachariah R, Manzi M et al. (2009) Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 594600.
  • Mermin J, Ekwaru JP, Liechty CA et al. (2006) Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. Lancet 367, 12561261.
  • Nachega JB, Hislop M, Dowdy DW et al. (2006) Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. Journal of Acquired Immunodeficiency Syndrome 43, 7884.
  • Philips M, Zachariah R & Venis S (2008) Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet 371, 682684.
  • Renaud-Thery F, Nguimfack BD, Vitoria M et al. (2007) Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens. AIDS 21(Suppl 4), S89S95.
  • Rosen S, Fox MP & Gill CJ (2007) Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Medicine 4, e298.
  • Souteyrand YP, Collard V, Moatti JP, Grubb I & Guerma T (2008) Free care at point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries. AIDS 22(Suppl 1), S161S168.
  • Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ & Garenne ML (2008) Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet 372, 893901.
  • Wood R, Kaplan R, Bekker LG, Brown S & Rivett U (2008) The utility of pharmacy dispensing data for ART programme evaluation and early identification of patients lost to follow-up. Southern African Journal of HIV Medicine 9, 4448.
  • World Health Organization (2009) Rapid Advice. Antiretroviral Therapy for HIV Infection in Adults and Adolescents. World Health Organization, Geneva. http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf (accessed 12 January 2010).
  • World Health Organization, UNAIDS, UNICEF (2009) Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report 2009. World Health Organization, Geneva. http://www.who.int/hiv/pub/tuapr_2009_en.pdf (accessed 12 January 2010).
  • Yu JKL, Chen SCC, Wang KY et al. (2007) True outcomes for patients on antiretroviral therapy who are “lost to follow up” in Malawi. Bulletin of the World Health Organization 85, 550554.
  • Zachariah R, Harries AD, Manzi M et al. (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS ONE 1, e121.
  • Zachariah R, Teck R, Buhendwa L et al. (2007) Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene 101, 7984.
  • Zachariah R, Van Engelgem I, Massaquoi M et al. (2008) Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 102, 288293.